Thomas McPhaul
Overview
Explore the profile of Thomas McPhaul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sinan H, Cunningham D, Sleiman E, Petry D, McPhaul T, Visvanathan K, et al.
JCO Precis Oncol
. 2025 Feb;
9:e2400494.
PMID: 39938008
Purpose: Current guidelines recommend offering genetic susceptibility testing to individuals with pancreatic cancer regardless of family history, but previous studies have reported only moderate test uptake, highlighting the need for...
2.
Wu P, Menso J, Zhang S, McPhaul T, Zhao F, Huang L, et al.
Surg Endosc
. 2024 Oct;
38(12):7243-7252.
PMID: 39390232
Background: The recent International Study Group for Pancreatic Surgery (ISGPS) risk classification for postoperative pancreatic fistula (grade B/C) was developed based on data from open and mixed minimally invasive pancreatoduodenectomy....
3.
Wang J, Gai J, Zhang T, Niu N, Qi H, Thomas 2nd D, et al.
Sci Adv
. 2024 Feb;
10(6):eadk1827.
PMID: 38324679
Radiotherapy is hypothesized to have an immune-modulating effect on the tumor microenvironment (TME) of pancreatic ductal adenocarcinoma (PDAC) to sensitize it to anti-PD-1 antibody (a-PD-1) treatment. We collected paired pre-...
4.
Heumann T, Judkins C, Li K, Lim S, Hoare J, Parkinson R, et al.
Nat Commun
. 2023 Jun;
14(1):3650.
PMID: 37339979
A neoadjuvant immunotherapy platform clinical trial allows for rapid evaluation of treatment-related changes in tumors and identifying targets to optimize treatment responses. We enrolled patients with resectable pancreatic adenocarcinoma into...
5.
Xie F, Ding D, Lin C, Cunningham D, Wright M, Javed A, et al.
JCO Precis Oncol
. 2022 Jun;
6:e2100404.
PMID: 35737913
Purpose: Genetic alterations in many components of the homologous recombination, DNA damage response, and repair (HR-DDR) pathway are involved in the hereditary cancer syndromes, including familial pancreatic cancer. HR-DDR genes...